SEP 11, 2015 6:28 PM PDT

Restoring Sight to the Blind

WRITTEN BY: Kerry Evans
One Michigan-based company thinks algae may hold a cure for blindness.  RetroSense Therapeutics will soon conduct a clinical trial to treat blindness using a light-sensitive protein from the green algae Chlamydomonas reinhardtii.
 
C. reinhardtii is a single-celled green algae whose spherical cells are about 10 microns in diameter.  It is commonly found in soil and freshwater, where it uses an eyespot to sense light for photosynthesis, and swims towards it using flagella.  Chlamydomonas species produce a light-sensing protein called channelrhodopsin-2, and it’s this protein that could literally restore sight to the blind.  
 
Chlamydomonas are single-celled green algae.
 
Channelrhodopsins are light-gated ion channels.  These transmembrane proteins form ion channels that change conformation in response to light, causing the channel to open or close.  In Chlamydomonas, the ion channels are linked to flagella function, allowing the cells to travel towards a light source.  Using gene therapy, RetroSense plans to insert the channelrhodopsin-2 gene into the retinal neurons of people suffering blindness due to conditions such as macular degeneration and retinitis pigmentosa.  In human retinal neurons, channelrhodopsin-2 should excite the neurons in response to light.  
 
This isn’t the first time Chlamydomonas has been in the news.  Because it is simple to grow and its genome can be easily manipulated, Chlamydomonas is widely used to produce “biopharmaceuticals”. Such therapeutics include human papilloma virus and malaria vaccines, and even a “designer” cancer drug.  It has even been considered as a clean source of hydrogen fuel because it can perform photosynthesis in the absence of oxygen, producing hydrogen as a byproduct.  
 
Check out the following video for a summary of the research being done on channelrhodopsins and blindness.
 

 
Sources: Wired, Rice University, Wikipedia, RetroSense Therapeutics, NIH, Foundation Fighting Blindness, Business Wire, Phys.org
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
OCT 03, 2020
Clinical & Molecular DX
Test Diagnoses Dementia While You Sleep by Estimating Your Brain Age
OCT 03, 2020
Test Diagnoses Dementia While You Sleep by Estimating Your Brain Age
Researchers at Harvard have discovered a novel diagnostic marker of dementia for identifying undiagnosed patients or tho ...
OCT 08, 2020
Immunology
Air Pollution Particles Detected in the Placenta, Immune Cells Mop Them Up
OCT 08, 2020
Air Pollution Particles Detected in the Placenta, Immune Cells Mop Them Up
Tiny, black particles much like those found in polluted air have been found in the placentas of pregnant women, as repor ...
OCT 12, 2020
Drug Discovery & Development
In vitro glycoengineering - Suitability for BioPharma manufacturing
OCT 12, 2020
In vitro glycoengineering - Suitability for BioPharma manufacturing
Introduction The importance of Fc glycosylation of monoclonal antibodies (mAbs) with regard to biological activity is wi ...
OCT 13, 2020
Clinical & Molecular DX
Test for Diabetes Checks If the Liver Is Responding
OCT 13, 2020
Test for Diabetes Checks If the Liver Is Responding
Glucagon is a hormone that prevents blood glucose levels from dropping too low by stimulating the liver to convert store ...
OCT 13, 2020
Cell & Molecular Biology
A Small Part of the Brain May Transmit Inflammation From Mom to Fetus
OCT 13, 2020
A Small Part of the Brain May Transmit Inflammation From Mom to Fetus
There is still a lot we don't know about the brain, and especially about two small bits of tissue deep within it called ...
OCT 22, 2020
Neuroscience
Psychedelic Experiences Reduce Narcissistic Personality Traits
OCT 22, 2020
Psychedelic Experiences Reduce Narcissistic Personality Traits
Researchers from the UK have found that psychedelic drugs can positively affect narcissistic personality traits- by redu ...
Loading Comments...